fda update on semaglutide Warns Certain Forms of Compounded Off-brand Ozempic and Wegovy weight-loss
Description
Genetic predispositions in GLP1R, GIPR, and metabolic genes may provide context for expected response patterns but do not determine exact medication response
That led to versions of those medications Wegovy and Zepbound which are specifically approved for the treatment of obesity
doi: 10.1210/endrev/bnac018
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis
